Volume 64, Issue 1, Pages (July 2003)

Slides:



Advertisements
Similar presentations
Kamyar Kalantar-Zadeh  Kidney International 
Advertisements

Volume 54, Issue 4, Pages (October 1998)
Volume 65, Issue 6, Pages (June 2004)
Volume 57, Issue 5, Pages (May 2000)
Volume 54, Issue 2, Pages (August 1998)
Long-term evolution of cardiomyopathy in dialysis patients
Plasma sodium and hypertension
Volume 70, Issue 8, Pages (October 2006)
Anemia management in chronic kidney disease
ESRD Care Within the US Department of Veterans Affairs: A Forward-Looking Program With an Illuminating Past  Suzanne Watnick, MD, Susan T. Crowley, MD 
End-stage renal disease in developing countries
Volume 58, Issue 4, Pages (October 2000)
Volume 57, Issue 5, Pages (May 2000)
Volume 61, Issue 2, Pages (February 2002)
Pharmacokinetics and pharmacodynamics of oral tolvaptan in patients with varying degrees of renal function  Susan E. Shoaf, Patricia Bricmont, Suresh.
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Reassessment of the care of the patient with chronic kidney disease
Volume 80, Issue 10, Pages (November 2011)
Volume 75, Issue 11, Pages (June 2009)
Volume 54, Issue 2, Pages (August 1998)
Volume 58, Issue 1, Pages (July 2000)
Kamyar Kalantar-Zadeh  Kidney International 
Is there a pharmacologic basis for combination renin axis blockade?
Volume 63, Issue 2, Pages (February 2003)
Abnormalities in lipoprotein metabolism in hemodialysis patients
Methotrexate in the urine
Comorbidity and confounding in end-stage renal disease
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
Volume 74, Issue 3, Pages (August 2008)
Volume 68, Issue 1, Pages (July 2005)
N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment  Martina Franz, Wolfgang Woloszczuk, Walter.
Volume 70, Issue 11, Pages (December 2006)
Nephrology Crosswords: Hemodialysis
Volume 87, Issue 2, Pages (February 2015)
Volume 66, Issue 1, Pages (July 2004)
Gentamicin pharmacokinetics during slow daily home hemodialysis
Bisphosphonate safety and efficacy in chronic kidney disease
The calcium–phosphorus in guidelines for CKD-MBD
Volume 70, Issue 12, Pages (December 2006)
Blood pressure targets in hemodialysis patients
Volume 65, Issue 6, Pages (June 2004)
Volume 61, Issue 1, Pages (January 2002)
A physician's perseverance uncovers problems in a key nephrology study
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Elevated risk of stroke among patients with end-stage renal disease
Volume 87, Issue 3, Pages (March 2015)
Alternate-day dialysis may be needed for hemodialysis patients
Long-term evolution of cardiomyopathy in dialysis patients
The global challenge of chronic kidney disease
Nephrology Crossword: Glomerulonephritis
V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen 
Volume 54, Issue 4, Pages (October 1998)
Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients  B. Bammens, P. Evenepoel, H. Keuleers,
Current status of maintenance hemodialysis in Beijing, China
Organ transplantation goes to the movies
Volume 64, Issue 3, Pages (September 2003)
Volume 72, Issue 2, Pages (July 2007)
Volume 80, Issue 10, Pages (November 2011)
Volume 60, Issue 6, Pages (December 2001)
Charles A. Herzog  Kidney International 
Volume 70, Issue 3, Pages (August 2006)
Volume 70, Issue 5, Pages (September 2006)
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Peter Stenvinkel, Olof Heimbürger, Catherine H. Tuck, Lars Berglund 
The Ebf1 knockout mouse and glomerular maturation
Characteristics of sudden death in hemodialysis patients
Volume 66, Issue 5, Pages (November 2004)
Volume 60, Issue 1, Pages (July 2001)
Presentation transcript:

Volume 64, Issue 1, Pages 290-294 (July 2003) Pharmacokinetics of oral micronized β-estradiol in postmenopausal women receiving maintenance hemodialysis  Catherine Stehman-Breen, Gail Anderson, Debbie Gibson, Annamaria T. Kausz, Susan Ott  Kidney International  Volume 64, Issue 1, Pages 290-294 (July 2003) DOI: 10.1046/j.1523-1755.2003.00073.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Estradiol serum concentrations obtained at steady state during one dosage interval for ESRD and healthy control subjects. Mean ± standard deviations are plotted. Kidney International 2003 64, 290-294DOI: (10.1046/j.1523-1755.2003.00073.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Estrone serum concentrations obtained at steady state during one dosage interval for ESRD and healthy control subjects. Mean ± standard deviations are plotted. Kidney International 2003 64, 290-294DOI: (10.1046/j.1523-1755.2003.00073.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Free estradiol serum concentrations obtained at steady state during one dosage interval for healthy control subjects and ESRD subjects. Mean ± standard deviations are plotted. Kidney International 2003 64, 290-294DOI: (10.1046/j.1523-1755.2003.00073.x) Copyright © 2003 International Society of Nephrology Terms and Conditions